دورية أكاديمية
Ascorbate as a bioactive compound in cancer therapy: the old classic strikes back
| العنوان: | Ascorbate as a bioactive compound in cancer therapy: the old classic strikes back |
|---|---|
| المؤلفون: | González Montero, Jaime, Chichiarelli, Silvia, Eufemi, Margherita, Altieri, Fabio, Saso, Luciano, Rodrigo Salinas, Ramón |
| المصدر: | Molecules |
| بيانات النشر: | MDPI |
| سنة النشر: | 2022 |
| المجموعة: | Universidad de Chile: Repositorio académico |
| مصطلحات موضوعية: | Cancer, Ascorbate, Oxidative stress, Ferroptosis, Iron |
| الوصف: | Cancer is a disease of high mortality, and its prevalence has increased steadily in the last few years. However, during the last decade, the development of modern chemotherapy schemes, new radiotherapy techniques, targeted therapies and immunotherapy has brought new hope in the treatment of these diseases. Unfortunately, cancer therapies are also associated with frequent and, sometimes, severe adverse events. Ascorbate (ascorbic acid or vitamin C) is a potent water-soluble antioxidant that is produced in most mammals but is not synthesised endogenously in humans, which lack enzymes for its synthesis. Ascorbate has antioxidant effects that correspond closely to the dose administered. Interestingly, this natural antioxidant induces oxidative stress when given intravenously at a high dose, a paradoxical effect due to its interactions with iron. Importantly, this deleterious property of ascorbate can result in increased cell death. Although, historically, ascorbate has been reported to exhibit anti-tumour properties, this effect has been questioned due to the lack of available mechanistic detail. Recently, new evidence has emerged implicating ferroptosis in several types of oxidative stress-mediated cell death, such as those associated with ischemia-reperfusion. This effect could be positively modulated by the interaction of iron and high ascorbate dosing, particularly in cell systems having a high mitotic index. In addition, it has been reported that ascorbate may behave as an adjuvant of favourable anti-tumour effects in cancer therapies such as radiotherapy, radio-chemotherapy, chemotherapy, immunotherapy, or even in monotherapy, as it facilitates tumour cell death through the generation of reactive oxygen species and ferroptosis. In this review, we provide evidence supporting the view that ascorbate should be revisited to develop novel, safe strategies in the treatment of cancer to achieve their application in human medicine. ; Versión publicada - versión final del editor |
| نوع الوثيقة: | article in journal/newspaper |
| وصف الملف: | application/pdf |
| اللغة: | English |
| العلاقة: | Molecules 2022, 27, 3818; https://repositorio.uchile.cl/handle/2250/186797Test |
| DOI: | 10.3390/molecules27123818 |
| الإتاحة: | https://doi.org/10.3390/molecules27123818Test https://repositorio.uchile.cl/handle/2250/186797Test |
| حقوق: | Attribution-NonCommercial-NoDerivs 3.0 United States ; http://creativecommons.org/licenses/by-nc-nd/3.0/usTest/ |
| رقم الانضمام: | edsbas.677BDD92 |
| قاعدة البيانات: | BASE |
| DOI: | 10.3390/molecules27123818 |
|---|